CPHI vs EXAS · rev $4.1M vs rev $2.76B
China Pharma Holdings Inc (CPHI) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CPHI currently screens at market cap $29.0M. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CPHI and EXAS stock pages for the full models.
Not investment advice.